$CLVT
CLARIVATE PLC Stock $clvt

$clvt Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000176404621000076 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q1
Revenue	$428.4M	$455.6M	$240.6M
YoY Change	78.06%	78.66%	2.81%
Cost Of Revenue	$147.9M	$134.1M	$82.70M
YoY Change	78.84%	62.55%	-7.39%
Gross Profit	$280.5M	$321.5M	$157.9M
YoY Change	77.64%	86.38%	9.05%
Gross Profit Margin	65.48%	70.57%	65.63%
Selling, General & Admin	$134.3M	$186.1M	$133.1M
YoY Change	0.94%	100.97%	44.16%
% of Gross Profit	47.88%	57.88%	84.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$131.6M	$127.0M	$2.329M
YoY Change	5550.49%	129.66%	13.55%
% of Gross Profit	46.92%	39.5%	1.47%
Operating Expenses	$462.6M	$244.2M	$268.9M
YoY Change	72.05%	67.03%	3.45%
Operating Profit	-$69.50M	-$9.621M	-$28.31M
YoY Change	145.51%	-41.45%	9.21%
Interest Expense	$37.40M	-$39.60M	$30.94M
YoY Change	20.88%	-37.93%	-6.53%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$55.70M	-$10.10M	-$114.9M
YoY Change	-51.51%	-87.41%	94.65%
Income Tax	$300.0K	-$16.50M	$14.75M
% Of Pretax Income
Net Earnings	-$56.00M	-$13.73M	-$129.6M
YoY Change	-56.8%	-83.81%	118.75%
Net Earnings / Revenue	-13.07%	-3.01%	-53.88%
Basic Earnings Per Share	-$0.09	-$0.02	-$0.38
Diluted Earnings Per Share	-$0.17	-$0.05	-$0.38
COMMON SHARES
Basic Shares Outstanding	602.3M shares	606.0M shares
Diluted Shares Outstanding	612.6M shares

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$399.0M	$258.0M	$308.0M
YoY Change	29.55%	239.47%	10166.67%
Cash & Equivalents	$399.0M	$257.7M	$308.0M
Short-Term Investments
Other Short-Term Assets	$230.2M	$79.15M	$22.10M
YoY Change	941.76%	573.62%
Inventory
Prepaid Expenses	$64.39M	$58.27M	$52.10M
Receivables	$706.9M	$737.7M	$343.2M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.414B	$1.148B	$728.2M
YoY Change	94.17%	132.74%	24174.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.57M	$36.27M	$22.95M
YoY Change	46.23%	101.01%
Goodwill	$6.246B	$6.043B	$1.823B
YoY Change	242.63%	355.03%
Intangibles	$7.266B	$7.370B	$2.282B
YoY Change	218.38%	303.05%
Long-Term Investments
YoY Change
Other Assets	$42.50M	$31.33M	$22.82M
YoY Change	86.27%	68.17%
Total Long-Term Assets	$13.70B	$13.64B	$4.271B
YoY Change	220.79%	313.64%	510.99%
TOTAL ASSETS
Total Short-Term Assets	$1.414B	$1.148B	$728.2M
Total Long-Term Assets	$13.70B	$13.64B	$4.271B
Total Assets	$15.11B	$14.79B	$4.999B
YoY Change	202.34%	290.11%	612.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$94.55M	$82.04M	$28.58M
YoY Change	230.78%	210.07%	376.38%
Accrued Expenses	$532.0M	$752.0M	$265.0M
YoY Change	100.75%	315.47%
Deferred Revenue	$769.0M	$707.3M	$472.1M
YoY Change	62.89%	73.65%	2.2%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$28.60M	$28.60M	$12.60M
YoY Change	126.98%	217.78%
Total Short-Term Liabilities	$1.467B	$1.423B	$778.3M
YoY Change	88.54%	118.6%	11018.86%
LONG-TERM LIABILITIES
Long-Term Debt	$3.453B	$3.458B	$1.915B
YoY Change	80.28%	112.32%
Other Long-Term Liabilities	$62.14M	$49.45M	$18.55M
YoY Change	234.95%	161.74%	-22.7%
Total Long-Term Liabilities	$3.515B	$3.507B	$1.934B
YoY Change	81.76%	112.89%	7958.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.467B	$1.423B	$778.3M
Total Long-Term Liabilities	$3.515B	$3.507B	$1.934B
Total Liabilities	$5.718B	$5.756B	$2.906B
YoY Change	96.75%	136.78%	9274.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.236B	-$1.251B
YoY Change		48.34%
Common Stock	$10.11B	$9.989B	$3.033B
YoY Change	233.31%	352.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	6.326M shares
Shareholders Equity	$9.119B	$9.035B	$1.926B
YoY Change
Total Liabilities & Shareholders Equity	$15.11B	$14.79B	$4.999B
YoY Change	202.34%	290.11%	612.12%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q1
OPERATING ACTIVITIES
Net Income	-$56.00M	-$13.73M	-$129.6M
YoY Change	-56.8%	-83.81%	118.75%
Depreciation, Depletion And Amortization	$131.6M	$127.0M	$2.329M
YoY Change	5550.49%	129.66%	13.55%
Cash From Operating Activities	$174.0M	$135.5M	$46.11M
YoY Change	277.39%	2556.86%	8.6%
INVESTING ACTIVITIES
Capital Expenditures	$33.00M	-$29.10M	$19.40M
YoY Change	70.15%	11.07%	-423.25%
Acquisitions	-$400.0K		$885.3M
YoY Change	-100.05%
Other Investing Activities	$400.0K	-$1.997B	-$881.6M
YoY Change	-100.05%	2819.44%
Cash From Investing Activities	-$32.60M	-$2.026B	-$901.0M
YoY Change	-96.38%	2041.65%	15024.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$540.6M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$6.600M	1.557B	$1.092B
YoY Change	-100.6%	1862.8%	-3326.17%
NET CHANGE
Cash From Operating Activities	$174.0M	135.5M	$46.11M
Cash From Investing Activities	-$32.60M	-2.026B	-$901.0M
Cash From Financing Activities	-$6.600M	1.557B	$1.092B
Net Change In Cash	$143.5M	-334.0M	$234.7M
YoY Change	-38.87%	3174.51%	9403.32%
FREE CASH FLOW
Cash From Operating Activities	$174.0M	$135.5M	$46.11M
Capital Expenditures	$33.00M	-$29.10M	$19.40M
Free Cash Flow	$141.0M	$164.6M	$26.71M
YoY Change	427.87%	425.88%	-44.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001764046
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	4334000
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1600000	USD
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-38911
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	CLARIVATE PLC
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Friars House,
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	160 Blackfriars Road
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SE1 8EZ
CY2021Q1	dei	Entity Address Country EntityAddressCountry	GB
CY2021Q1	dei	Country Region CountryRegion	44
CY2021Q1	dei	City Area Code CityAreaCode	207
CY2021Q1	dei	Security12b Title Security12bTitle	Ordinary shares
CY2021Q1	dei	Trading Symbol TradingSymbol	CLVT
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	611792824	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	399006000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	257730000	USD
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	13513000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11278000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8340000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	706879000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	737733000	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	64392000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58273000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	230218000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	262494000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	1414008000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1327508000	USD
CY2021Q1	clvt	Computer Hardware And Other Property Net ComputerHardwareAndOtherPropertyNet	33565000	USD
CY2020Q4	clvt	Computer Hardware And Other Property Net ComputerHardwareAndOtherPropertyNet	36267000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7266497000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7370350000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	6246384000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6252636000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42504000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	47944000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	27348000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1569767000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	29786000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84052000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	132356000	USD
CY2021Q1	us-gaap	Assets Assets	15114358000	USD
CY2020Q4	us-gaap	Assets Assets	15196847000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	94548000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	82038000	USD
CY2021Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	541351000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	716356000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	769030000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	707318000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	33896000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35455000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	28600000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	28600000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1467425000	USD
CY2021Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3453082000	USD
CY2020Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3457900000	USD
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	257944000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	312751000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	45404000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	41399000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	62143000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	67722000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	351937000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	362261000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79651000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104324000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	5717586000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	5916124000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	611355226	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	611355226	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	606329598	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	606329598	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	10109449000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	9989284000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	523359000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	503521000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1236036000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1212082000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9396772000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9280723000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15114358000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15196847000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240592000	USD
CY2021Q1	clvt	Cost Of Revenues Excluding Depreciation And Amortization CostOfRevenuesExcludingDepreciationAndAmortization	138741000	USD
CY2020Q1	clvt	Cost Of Revenues Excluding Depreciation And Amortization CostOfRevenuesExcludingDepreciationAndAmortization	82682000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	111345000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	133055000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	3333000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2329000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	128321000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49112000	USD
CY2021Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	64667000	USD
CY2020Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	7754000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-16230000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6032000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	462637000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	268900000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-34207000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28308000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55632000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-51215000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	17008000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-83940000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	37393000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	30940000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20385000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-114880000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3569000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14753000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	608598235	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	343129833	shares
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23954000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1340000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2890000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	4000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	67000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18502000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5513000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	19838000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4116000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-138103000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1248599000	USD
CY2020Q1	clvt	Stock Issued During Period Value Public Warrants Exercised StockIssuedDuringPeriodValuePublicWarrantsExercised	277526000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1182000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10302000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	539714000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16384000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1925681000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9280723000	USD
CY2021Q1	clvt	Stock Issued During Period Value Private Warrants Exercised StockIssuedDuringPeriodValuePrivateWarrantsExercised	3592000	USD
CY2021Q1	clvt	Stock Issued During Period Value Private Warrants Exercised StockIssuedDuringPeriodValuePrivateWarrantsExercised	3592000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5074000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	4489000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	105509000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10479000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23954000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	19838000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9396772000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23954000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	131654000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51441000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3122000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2021Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	162000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	4214000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10479000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16502000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	40984000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2021Q1	clvt	Gain Loss On Foreign Currency Forward Contracts GainLossOnForeignCurrencyForwardContracts	1023000	USD
CY2021Q1	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	-27680000	USD
CY2020Q1	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	1187000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-51215000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55632000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-586000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-2332000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-1008000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3494000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7015000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-44221000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29279000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7170000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7349000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	927000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-54644000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	13746000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	758000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-9725000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-13222000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	65988000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40726000	USD
CY2021Q1	clvt	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-7468000	USD
CY2020Q1	clvt	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-5919000	USD
CY2021Q1	clvt	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	25666000	USD
CY2020Q1	clvt	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	5876000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2839000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-52109000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	174037000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46106000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32972000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19395000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-433000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	885323000	USD
CY2021Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2020Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	3751000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32539000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-900967000	USD
CY2021Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	7150000	USD
CY2020Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	3150000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2020Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	65000000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5014000	USD
CY2021Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4115000	USD
CY2021Q1	clvt	Proceeds From Debt Restructure ProceedsFromDebtRestructure	0	USD
CY2020Q1	clvt	Proceeds From Debt Restructure ProceedsFromDebtRestructure	360000000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	540597000	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	277526000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5074000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1182000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4489000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10420000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6565000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1091606000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8578000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2013000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	143511000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	234732000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	257730000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76130000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	11278000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	269008000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76139000	USD
CY2021Q1	us-gaap	Nature Of Operations NatureOfOperations	Background and Nature of Operations <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clarivate Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), is a public limited company organized under the laws of Jersey, Channel Islands. We were initially registered on January 7, 2019, and at our 2020 annual general meeting, our shareholders approved a change of our corporate name from “Clarivate Analytics Plc” to “Clarivate Plc”. Pursuant to the definitive agreement entered into to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation, ("Churchill") (the “2019 Transaction”), the Company was formed for the purposes of completing the 2019 Transaction and related transitions and carrying on the business of Jersey and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a provider of proprietary and comprehensive content, analytics, professional services and workflow solutions that enables users across government and academic institutions, life science companies and research and development (“R&D”) intensive corporations to discover, protect and commercialize their innovations. Clarivate has two reportable segments: Science and Intellectual Property ("IP"). Our segment structure is organized to address customer needs by product line. Our Science segment consists of our Academic and Life Sciences Product Lines. Both provide curated, high-value, structured information that is delivered and embedded into the workflows of our customers, which include research intensive corporations, life science organizations and universities world-wide. Our IP segment consists of our Patent, Trademark, Domain and IP Management Product Lines. These Product Lines helps manage customer's end-to-end portfolios of intellectual property from patents to trademarks to corporate website domains. See Note 21 - Segment Information, for additional information on the Company's reportable segments. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, we entered into an Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated February 26, 2019, and Amendment No. 2 to the Agreement and Plan of Merger, dated March 29, 2019, collectively, the “Merger Agreement”) by and among Churchill, Jersey, CCC Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Clarivate (“Delaware Merger Sub”), Camelot Merger Sub (Jersey) Limited, a private limited company organized under the laws of Jersey, Channel Islands and wholly owned subsidiary of Clarivate (“Jersey Merger Sub”), and the Company, which, among other things, provided for (i) Jersey Merger Sub to be merged with and into Jersey with Jersey being the surviving company in the merger (the “Jersey Merger”) and (ii) Delaware Merger Sub to be merged with and into Churchill with Churchill being the surviving corporation in the merger (the “Delaware Merger”), and together with the Jersey Merger, the “Mergers”.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 13, 2019, the 2019 Transaction was consummated, and Clarivate became the sole managing member of Jersey, operating and controlling all of the business and affairs of Jersey, through Jersey and its subsidiaries. Following the consummation of the 2019 Transaction on May 13, 2019, the Company’s ordinary shares and warrants began trading on the New York Stock Exchange. All of the Company’s public warrants have subsequently been redeemed. See Note 16 - Shareholders’ Equity for further information regarding the redemption of the Company’s public warrants.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Transaction was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Under this method of accounting, Churchill was treated as the "acquired" company for financial reporting purposes. This determination was primarily based on post 2019 Transaction relative voting rights, composition of the governing board, size of the two entities pre-merger, and intent of the 2019 Transaction. Accordingly, for accounting purposes, the 2019 Transaction was treated as the equivalent of the Company issuing stock for the net assets of Churchill. The net assets of Churchill were stated at historical cost, with no goodwill or other intangible assets resulting from the 2019 Transaction. Reported amounts from operations included herein prior to the 2019 Transaction are those of Jersey.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company consummated a public offering of 27,600,000 ordinary shares at $20.25 per share. In June 2020, the Company consummated a public offering of 50,400,000 of our ordinary shares at a share price of $22.50 per share. Of the 50,400,000 ordinary shares, 14,000,000 were ordinary shares offered by Clarivate and 36,400,000 were ordinary shares offered by selling shareholders. The Company received approximately $304,030 in net proceeds from the sale of its ordinary shares, after deducting underwriting discounts and estimated offering expenses payable. We used the net proceeds, in conjunction with the new $1,600,000 incremental term loan facility available to Clarivate on October 1, 2020, and cash on the balance sheet to fund the repayment of CPA Global's parent company outstanding debt of $2,055,822. The Company did not receive any proceeds from the sale of ordinary shares by the selling shareholders. Additionally, in connection with the acquisition of CPA Global, on October 1, 2020, the Company issued 216,683,778 shares to Redtop Holdings Limited, a portfolio company of Leonard Green & Partners, L.P. representing approximately 35% ownership of Clarivate. After giving </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect to the Company's acquisition of CPA Global, Onex Corporation and Baring owned approximately 11.4% and 4.5%, respectively, of the Company's ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization characterized COVID-19 as a pandemic. The rapid spread of COVID-19 and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. However, we continue to assess the potential effect on our financial position, results of operations, and cash flows. If the global pandemic continues to evolve into a prolonged crisis, the effects could have an adverse impact on the Company's results of operations, financial condition and cash flows.</span></div>
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	412519000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310871000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	399006000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	308021000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	13513000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	2850000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	412519000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310871000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	27334000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	11405000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2583000	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	4797000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6138000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9528000	USD
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	27600000	shares
CY2020Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.25
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	50400000	shares
CY2020Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	22.50
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	50400000	shares
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	304030000	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1600000	USD
CY2020Q4	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	8839599000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2861000	USD
CY2019	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	-18431000	USD
CY2021Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	715219000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	746478000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8340000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	706879000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	737733000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16511000	USD
CY2021Q1	clvt	Accounts Receivable Allowance For Credit Loss Additional Provisions AccountsReceivableAllowanceForCreditLossAdditionalProvisions	1495000	USD
CY2020	clvt	Accounts Receivable Allowance For Credit Loss Additional Provisions AccountsReceivableAllowanceForCreditLossAdditionalProvisions	4339000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2069000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2021Q1	clvt	Accounts Receivable Allowancefor Credit Loss Accounting Change AccountsReceivableAllowanceforCreditLossAccountingChange	0	USD
CY2020	clvt	Accounts Receivable Allowancefor Credit Loss Accounting Change AccountsReceivableAllowanceforCreditLossAccountingChange	10097000	USD
CY2021Q1	clvt	Accounts Receivable Allowance For Credit Loss Increase Decrease From Exchange Differences AccountsReceivableAllowanceForCreditLossIncreaseDecreaseFromExchangeDifferences	169000	USD
CY2020	clvt	Accounts Receivable Allowance For Credit Loss Increase Decrease From Exchange Differences AccountsReceivableAllowanceForCreditLossIncreaseDecreaseFromExchangeDifferences	3000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8340000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2069000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	755000	USD
CY2020Q1	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2021Q1	clvt	Noncash Impairment Leases NoncashImpairmentLeases	40984000	USD
CY2020Q1	clvt	Noncash Impairment Leases NoncashImpairmentLeases	0	USD
CY2021Q1	clvt	Decrease In Operating Lease Right Of Use Asset DecreaseInOperatingLeaseRightOfUseAsset	40984000	USD
CY2021Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-3104000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	71374000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73068000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37809000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36801000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33565000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36267000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	3333000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2329000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7370350000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8171830000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1068294000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7103536000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8153014000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	943909000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7209105000	USD
CY2021Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8334791000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1068294000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7266497000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8314259000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	943909000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	128321000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49112000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1328045000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4700138000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-233582000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6252636000	USD
CY2021Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	-8121000	USD
CY2021Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1869000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	6246384000	USD
CY2020Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1737000	USD
CY2020Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.02183
CY2020Q2	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.01695
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	978000	USD
CY2021Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	1023000	USD
CY2020Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	0	USD
CY2021Q1	clvt	Decrease In Operating Lease Right Of Use Asset DecreaseInOperatingLeaseRightOfUseAsset	40984000	USD
CY2021Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-3104000	USD
CY2021Q1	clvt	Employee Phantom Share Plan Liability Current EmployeePhantomSharePlanLiabilityCurrent	171889000	USD
CY2020Q4	clvt	Employee Phantom Share Plan Liability Current EmployeePhantomSharePlanLiabilityCurrent	193162000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	130594000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63302000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	98481000	USD
CY2021Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	49729000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	67628000	USD
CY2021Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	42872000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	45119000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	213559000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	181372000	USD
CY2021Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	541351000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	716356000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	-52000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	-40000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-6000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	368000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	226000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	82000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	79000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-19000	USD
CY2021Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	392000	USD
CY2020Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	246000	USD
CY2021Q1	us-gaap	Debt Current DebtCurrent	28600000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3540250000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3547400000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	49346000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	51309000	USD
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9222000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9591000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	28600000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3453082000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3457900000	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1600000	USD
CY2021Q1	clvt	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	431454000	USD
CY2020Q1	clvt	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	242474000	USD
CY2021Q1	clvt	Contractwith Customer Liability Adjustments ContractwithCustomerLiabilityAdjustments	3024000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	428430000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240592000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	737733000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	707318000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	41399000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	706879000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	769030000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	45404000	USD
CY2021Q1	clvt	Increase Decrease In Contract With Customer Accounts Receivable IncreaseDecreaseInContractWithCustomerAccountsReceivable	30854000	USD
CY2021Q1	clvt	Increase Decrease In Contract With Customer Current Liability IncreaseDecreaseInContractWithCustomerCurrentLiability	-61712000	USD
CY2021Q1	clvt	Increase Decrease In Contract With Customer Non Current Liability IncreaseDecreaseInContractWithCustomerNonCurrentLiability	-4005000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	333858000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407325000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	19723000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	343177000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	472101000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	18774000	USD
CY2020Q1	clvt	Increase Decrease In Contract With Customer Accounts Receivable IncreaseDecreaseInContractWithCustomerAccountsReceivable	-9319000	USD
CY2020Q1	clvt	Increase Decrease In Contract With Customer Current Liability IncreaseDecreaseInContractWithCustomerCurrentLiability	-64776000	USD
CY2020Q1	clvt	Increase Decrease In Contract With Customer Non Current Liability IncreaseDecreaseInContractWithCustomerNonCurrentLiability	949000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	231275000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	105150000	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	74238000	USD
CY2021Q1	clvt	Revenue Remaining Performance Obligation Expected Timing Percentage RevenueRemainingPerformanceObligationExpectedTimingPercentage	0.486
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.514
CY2021Q1	clvt	Revenue Remaining Performance Obligation Percentage Expectedto Be Recognizedin12months RevenueRemainingPerformanceObligationPercentageExpectedtoBeRecognizedin12months	0.252
CY2021Q1	clvt	Revenue Remaining Performance Obligation Percentage Expected To Be Recognized In3 To5 Years RevenueRemainingPerformanceObligationPercentageExpectedToBeRecognizedIn3To5Years	0.257
CY2021Q1	clvt	Revenue Remaining Performance Obligation Percentage Expected To Be Recognized In6 To10 Years RevenueRemainingPerformanceObligationPercentageExpectedToBeRecognizedIn6To10Years	0.005
CY2021Q1	clvt	Common Stock Shares Subscription CommonStockSharesSubscription	0	shares
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	1
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	611355226	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2021Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	52800000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q1	clvt	Class Of Warrant Or Right Days From Which Warrants Or Rights Exercisable ClassOfWarrantOrRightDaysFromWhichWarrantsOrRightsExercisable	P30D
CY2019Q4	clvt	Number Of Warrants Exercised NumberOfWarrantsExercised	100114
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24132666	shares
CY2021Q1	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	2895638	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	60000000	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10660000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17469000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1400000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-2000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7024701	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	361000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2863000	USD
CY2019Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	52800000	shares
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q1	clvt	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	212174	shares
CY2021Q1	clvt	Class Of Warrant Or Right Shares Withheld For Exercise Price ClassOfWarrantOrRightSharesWithheldForExercisePrice	80610	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	131564	shares
CY2020Q1	clvt	Stock Issued During Period Shares Private Warrants Exercised StockIssuedDuringPeriodSharesPrivateWarrantsExercised	0	shares
CY2021Q1	clvt	Stock Issued During Period Shares Private Warrants Exercised StockIssuedDuringPeriodSharesPrivateWarrantsExercised	212174	shares
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5309713	shares
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3569000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20385000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14753000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-114880000	USD
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38149453000	shares
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23954000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-129633000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	608598235	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	343129833	shares
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5863000	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-15984000	USD
CY2021Q1	us-gaap	Other Operating Income OtherOperatingIncome	-246000	USD
CY2020Q1	us-gaap	Other Operating Income OtherOperatingIncome	169000	USD
CY2021Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-16230000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6032000	USD
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	428430000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240592000	USD
CY2021Q1	clvt	Adjusted Earnings Before Income Taxes Deprecation Amortization Interest Income And Expense AdjustedEarningsBeforeIncomeTaxesDeprecationAmortizationInterestIncomeAndExpense	164833000	USD
CY2020Q1	clvt	Adjusted Earnings Before Income Taxes Deprecation Amortization Interest Income And Expense AdjustedEarningsBeforeIncomeTaxesDeprecationAmortizationInterestIncomeAndExpense	78222000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3569000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14753000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	131654000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51441000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	37393000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	30940000	USD
CY2021Q1	clvt	Transition Services Agreement Costs TransitionServicesAgreementCosts	0	USD
CY2020Q1	clvt	Transition Services Agreement Costs TransitionServicesAgreementCosts	1551000	USD
CY2021Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	46000	USD
CY2020Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	2228000	USD
CY2021Q1	clvt	Deferred Revenues Adjustment DeferredRevenuesAdjustment	3024000	USD
CY2020Q1	clvt	Deferred Revenues Adjustment DeferredRevenuesAdjustment	1882000	USD
CY2021Q1	clvt	Transaction Related Costs TransactionRelatedCosts	-26639000	USD
CY2020Q1	clvt	Transaction Related Costs TransactionRelatedCosts	26689000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10660000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17469000	USD
CY2021Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	64667000	USD
CY2020Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	7754000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-51215000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55632000	USD
CY2021Q1	clvt	Other Reconciling Items Ebita To Net Income Loss Attributable To Parent OtherReconcilingItemsEBITAToNetIncomeLossAttributableToParent	15628000	USD
CY2020Q1	clvt	Other Reconciling Items Ebita To Net Income Loss Attributable To Parent OtherReconcilingItemsEBITAToNetIncomeLossAttributableToParent	-2484000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23954000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2021Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	0	USD
CY2020Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	0	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240592000	USD
CY2020Q1	clvt	Cost Of Revenues Excluding Depreciation And Amortization CostOfRevenuesExcludingDepreciationAndAmortization	82682000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	133055000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	2329000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	49112000	USD
CY2020Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	7754000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6032000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	268900000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-28308000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55632000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-83940000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	30940000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-114880000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14753000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	343129833	shares
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2890000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	67000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5513000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-138103000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1248599000	USD
CY2020Q1	clvt	Stock Issued During Period Value Public Warrants Exercised StockIssuedDuringPeriodValuePublicWarrantsExercised	277526000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51441000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1182000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10302000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	539714000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16384000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1925681000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	4214000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	16502000	USD
CY2020Q1	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	1187000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	55632000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-1008000	USD
CY2020Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7015000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29279000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7349000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-54644000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	758000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-13222000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-13222000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40726000	USD
CY2020Q1	clvt	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-5919000	USD
CY2020Q1	clvt	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	5876000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-52109000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46106000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19395000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	885323000	USD
CY2020Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	3751000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-900967000	USD
CY2020Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	3150000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	65000000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1182000	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5014000	USD
CY2020Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4115000	USD
CY2020Q1	clvt	Proceeds From Debt Restructure ProceedsFromDebtRestructure	360000000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	540597000	USD
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	277526000	USD
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	277526000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1182000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10420000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1091606000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2013000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	234732000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76130000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76139000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310871000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	308021000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	2850000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	310871000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	11405000	USD
CY2020Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	4797000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9528000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-13222000	USD
CY2020Q1	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	1187000	USD

Files In Submission

Name	View Source	Status
0001764046-21-000076-index-headers.html	Edgar Link	pending
0001764046-21-000076-index.html	Edgar Link	pending
0001764046-21-000076.txt	Edgar Link	pending
0001764046-21-000076-xbrl.zip	Edgar Link	pending
a41-may2020supplementalind.htm	Edgar Link	pending
a42-march2021xsupplemental.htm	Edgar Link	pending
clvt-20210331.htm	Edgar Link	pending
clvt-20210331.xsd	Edgar Link	pending
clvt-20210331_cal.xml	Edgar Link	unprocessable
clvt-20210331_def.xml	Edgar Link	unprocessable
clvt-20210331_htm.xml	Edgar Link	completed
clvt-20210331_lab.xml	Edgar Link	unprocessable
clvt-20210331_pre.xml	Edgar Link	unprocessable
exhibit31-q12021.htm	Edgar Link	pending
exhibit32-q12021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLVT
CLARIVATE PLC Stock $clvt

2021 Q1 Form 10-Q Financial Statement

#000176404621000076 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLVT CLARIVATE PLC Stock $clvt

2021 Q1 Form 10-Q Financial Statement

#000176404621000076 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLVT
CLARIVATE PLC Stock $clvt